Femtobiomed Inc. announced a private placement of 269,613 registered convertible preferred stock at a price of KRW 7,418 per share for gross proceeds of KRW 1,999,989,234 on September 7, 2023. The transaction has been approved by the board of directors of the company. The transaction will include participation from new investor, SV Gap-Coverage Fund No.

4.